Prof. David Paterson

David Paterson is a tenured Professor of Medicine at the Saw Swee Hock School of Public Health and the Yong Loo Lin School of Medicine, both at the National University of Singapore. He is also an Honorary Professor at the University of Queensland. Professor Paterson directs ADVANCE-ID (ADVANcing Clinical Evidence for Infectious Diseases), a clinical trials network comprising more than 40 hospitals across Asia. This network is jointly funded by the Wellcome Trust and a number of Singaporean institutions with an aim to conduct clinically important trials in the field of antimicrobial resistance (AMR). This comprises trials of antibiotics, diagnostics and prevention strategies. 

Dr. Richard Brandon

Richard Brandon is a co-founder and chief scientific office of Immunexpress. His experience in immunology and infectious disease, in both academia and industry, led to the underlying concept of Immunexpress technology. That is, that specific immune responses can be measured to identify patients with sepsis, and bacterial and viral infections. His passion is to develop technologies that improve outcomes for seriously ill patients suspected of sepsis. 

Dr. Catalina Carrasco  

Catalina Carrasco is Product Manager at Abacus dx. After finishing her PhD in Pharmacology, she was working in the academic sector for more than 10 years, holding position such as Assistant Professor at the University of Chile, Visiting Academic at The University of Queensland, and Research Fellow at Griffith Institute for Drug Discovery. One year ago, she moved into her role as Product Manager for Abacus dx, who represent T2 Biosystems and Immunexpress in the ANZ market. 

Abacus dx